Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing.
Cohen D, Hondelink LM, Solleveld-Westerink N, Uljee SM, Ruano D, Cleton-Jansen AM, von der Thüsen JH, Ramai SRS, Postmus PE, Graadt van Roggen JF, Hoppe BPC, Clahsen PC, Maas KW, Ahsmann EJM, Ten Heuvel A, Smedts F, van Rossem RN, van Wezel T. Cohen D, et al. Among authors: ahsmann ejm. J Thorac Oncol. 2020 Jun;15(6):1000-1014. doi: 10.1016/j.jtho.2020.01.019. Epub 2020 Jan 31. J Thorac Oncol. 2020. PMID: 32014610 Free article.
Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas.
de Haan LM, de Groen RAL, de Groot FA, Noordenbos T, van Wezel T, van Eijk R, Ruano D, Diepstra A, Koens L, Nicolae-Cristea A, Hartog WCED, Terpstra V, Ahsmann E, Dekker TJA, Sijs-Szabo A, Veelken H, Cleven AHG, Jansen PM, Vermaat JSP. de Haan LM, et al. Virchows Arch. 2023 Oct 18. doi: 10.1007/s00428-023-03676-6. Online ahead of print. Virchows Arch. 2023. PMID: 37851120
Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice.
Steeghs EMP, Vink GR, Elferink MAG, Voorham QJM, Gelderblom H, Nagtegaal ID; PATH Consortium Members; Grünberg K, Ligtenberg MJL; PATH consortium members. Steeghs EMP, et al. J Clin Pathol. 2021 Oct 21;75(10):706-11. doi: 10.1136/jclinpath-2021-207865. Online ahead of print. J Clin Pathol. 2021. PMID: 34675090 Free PMC article.
A novel flow cytometric assay for the quantification of adhesion of subsets within a heterogeneous cell population; analysis of lymphocyte function-associated antigen-1 (LFA-1)-mediated binding of bone marrow-derived primary tumour cells of patients with multiple myeloma.
Ahsmann EJ, Benschop RJ, de Gruyl TD, Faber JA, Lokhorst HM, Bloem AC. Ahsmann EJ, et al. Clin Exp Immunol. 1993 Sep;93(3):456-63. doi: 10.1111/j.1365-2249.1993.tb08201.x. Clin Exp Immunol. 1993. PMID: 8103718 Free PMC article.
A Case of Anti-SAE1 Dermatomyositis.
de Vries M, Schreurs MWJ, Ahsmann EJM, Spee-Dropkova M, Karim F. de Vries M, et al. Among authors: ahsmann ejm. Case Reports Immunol. 2022 Mar 4;2022:9000608. doi: 10.1155/2022/9000608. eCollection 2022. Case Reports Immunol. 2022. PMID: 35280599 Free PMC article.
The SCID mouse as a model for multiple myeloma.
Ahsmann EJ, van Tol MJ, Oudeman-Gruber J, Lokhorst H, Uytdehaag FG, Schuurman HJ, Bloem AC. Ahsmann EJ, et al. Br J Haematol. 1995 Feb;89(2):319-27. doi: 10.1111/j.1365-2141.1995.tb03307.x. Br J Haematol. 1995. PMID: 7873382